Squarepoint’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-212,916
| Closed | -$183K | – | 3071 |
|
|
2023
Q4 | $183K | Buy |
212,916
+73,257
| +52% | +$62.9K | ﹤0.01% | 2166 |
|
|
2023
Q3 | $149K | Buy |
+139,659
| New | +$149K | ﹤0.01% | 2185 |
|
|
2023
Q2 | – | Sell |
-71,443
| Closed | -$291K | – | 2958 |
|
|
2023
Q1 | $291K | Sell |
71,443
-27,324
| -28% | -$111K | ﹤0.01% | 1691 |
|
|
2022
Q4 | $496K | Buy |
98,767
+72,853
| +281% | +$366K | ﹤0.01% | 1462 |
|
|
2022
Q3 | $339K | Buy |
+25,914
| New | +$339K | ﹤0.01% | 1566 |
|
|
2022
Q2 | – | Sell |
-38,747
| Closed | -$591K | – | 2772 |
|
|
2022
Q1 | $591K | Buy |
38,747
+28,481
| +277% | +$434K | ﹤0.01% | 1410 |
|
|
2021
Q4 | $182K | Sell |
10,266
-5,810
| -36% | -$103K | ﹤0.01% | 2136 |
|
|
2021
Q3 | $338K | Sell |
16,076
-6,220
| -28% | -$131K | ﹤0.01% | 1575 |
|
|
2021
Q2 | $440K | Sell |
22,296
-1,743
| -7% | -$34.4K | ﹤0.01% | 1701 |
|
|
2021
Q1 | $699K | Buy |
24,039
+3,421
| +17% | +$99.5K | ﹤0.01% | 1312 |
|
|
2020
Q4 | $625K | Buy |
+20,618
| New | +$625K | ﹤0.01% | 1342 |
|
|
2020
Q3 | – | Sell |
-29,525
| Closed | -$583K | – | 2772 |
|
|
2020
Q2 | $583K | Buy |
+29,525
| New | +$583K | 0.01% | 1221 |
|